Francis Collins News
-
Rebecca Riggins, a Georgetown University cancer researcher, has had to freeze her work amid federal funding cuts brought on by sequestration. Literally.
-
President Barack Obama announced a U.S. campaign that may lead to new treatments for some of the least understood brain disorders, benefiting efforts by Pfizer Inc., Roche Holding AG and Eli Lilly & Co.
-
The U.S. will lock down prisoners, furlough Internal Revenue Service workers, and rely on Russia to get astronauts into space to cope with $85 billion in federal spending reductions due to begin tomorrow.
-
Butamax Advanced Biofuels LLC asked the U.S. Patent and Trademark Office to reexamine a disputed patent owned by Gevo Inc., the U.S. biotechnology company backed by the oil refiner Total SA and the specialty chemicals maker Lanxess AG.
-
Research using human embryonic stem- cell lines approved under President Barack Obama is accelerating, boosting a scientific field that’s been dogged by legal and political threats.
-
Medical researchers who are black are about one-third less likely than their white colleagues to win grants from the U.S. National Institutes of Health, a study commissioned by the government found.
-
About 35 percent of the $200 million the U.S. government planned to award this year in grants for embryonic stem cell research won’t be distributed after a judge’s ruling banned the funding.
-
The U.S. government said it will allow publication of research by scientists who re-engineered the avian influenza virus to make it more lethal.
-
Few government programs seem as sacrosanct as funding for medical research. Despite continuing U.S. budget constraints, both Democrats and Republicans regularly pledge to increase funding for the National Institutes of Health and other government medical research.
-
Intellectual Ventures Management LLC, a patent-licensing firm that claims to own more than 30,000 patents and to have earned almost $2 billion in licensing fees, filed three patent-infringement suits against technology companies yesterday.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page